Affiliation:
1. Department of Pediatrics, Ankara Education and Research Hospital , Ankara 06230, Turkey
2. Department of Pediatric Emergency, Ankara Education and Research Hospital , Ankara 06230, Turkey
3. Department of Pediatric Hematology, Ankara Education and Research Hospital , Ankara 06230, Turkey
Abstract
Abstract
Background
Limited data exist about the vaccination of children with idiopathic thrombocytopenic purpura (ITP) against vaccine preventable diseases. This study identified the vaccination status of children with ITP against hepatitis A, hepatitis B, measles, mumps, rubella and varicella, completed the immunization of children with inadequate immunization, re-evaluated post-vaccination antibody titers and identified probable vaccination-related complications.
Patients and methods
All of 46 children had chronic ITP were included. Seroconversion of hepatitis A, hepatitis B, varicella, measles, rubella and mumps vaccines was screened. All children with seronegative antibodies against vaccine preventable disease were given a vaccination appointment. Antibody levels were re-measured during a period ranging from 1 to 6 months. Potential complications were detected.
Results
There were 46 children with a mean age of 12.25 years. All children had chronic ITP and received intravenous immunoglobulin at least once previously. Considering the vaccination status, 50% (23 children) had vaccinations appropriate for their age, 47.8% (22 children) did not know their vaccination status and 2.2% (1 patient) did not have vaccinations. Seven children (15.2%) were seropositive for all antibody types and the remaining 39 children were scheduled for vaccination. Post-vaccination antibody titers confirmed that all children became seropositive for each disease. There was no complication in any patient.
Conclusion
Immunization against hepatitis B, hepatitis A, measles, mumps, rubella and varicella is insufficient in a considerable number of children with ITP, Hepatitis B Virus (HBV) and Hepatitis A Virus (HAV) immunization being the most frequently inadequate. After immunization, adequate seroconversion levels were achievable without complications.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pediatrics, Perinatology and Child Health
Reference17 articles.
1. Immune thrombocytopenia: American Society of Hematology Guidelines, 2019;Sahi;Indian Pediatr,2020
2. Immune thrombocytopenia—current diagnostics and therapy: recommendations of a joint working group of DGHO, ÖGHO, SGH, GPOH, and DGTI;Matzdorff;Oncol Res Treat,2018
3. Vaccination in children with autoimmune disorders and treated with various ımmunosuppressive regimens: a comprehensive review and practical guide;Blanchard-Rohner;Front Immunol,2021
4. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia;Schmidt;J Thromb Haemost,2021
5. Immune thrombocytopenia in children: consensus and controversies;Singh;Indian J Pediatr,2020